Fibrocell Announces Oral Presentation at 7th International Investigative Dermatology Meeting

Fibrocell Announces Oral Presentation at 7th International Investigative Dermatology Meeting

EXTON, PA — Fibrocell Science, Inc.Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, announced that an abstract will be presented in an oral session at the 7th International Investigative Dermatology (IID) meeting on May 19, 2018 at the Rosen Shingle Creek Resort in Orlando, Florida. The presentation will focus on the interim data from adult patients in the Phase 1 portion of the Phase 1/2 clinical trial of FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).

Concurrent Mini-Symposium 13: Clinical Research: Patient Outcomes Research
Presentation: A Phase 1/2 Study of Genetically-Corrected, Collagen VII Expressing Autologous Human Dermal Fibroblasts (FCX-007) Injected into the Skin of Patients with Recessive Dystrophic Epidermolysis Bullosa
Presenter: M. Peter Marinkovich, MD, Associate Professor of Dermatology at the Stanford University School of Medicine
Abstract ID: 591

READ:  Annovis Bio Issued European Patent for Method of Treating Alzheimer’s Disease with ANVS401

Fibrocell Conference Call & Webcast

On Monday, May 21, 2018 at 8:30 a.m. EDT, Fibrocell will host a conference call and webcast to discuss the interim results and progress of the Phase 1/2 clinical trial of FCX-007. A slide presentation summarizing the data will be referenced during the call and will be posted in the Investors section of the Company’s website www.fibrocell.com/investors/events under the event, “Fibrocell FCX-007 Conference Call & Webcast.” Following the presentation, there will be a question-and-answer session with John Maslowski, President and CEO of Fibrocell, and Alfred Lane, MD, Chief Medical Advisor of Fibrocell and Professor of Dermatology and Pediatrics (Emeritus) at the Stanford University School of Medicine.

To participate on the live call, please dial 866-548-4713 (domestic) or +1-323-794-2093 (international) and provide the conference code 5629866. The conference call will also be webcast live from the Investors section of Fibrocell’s website at www.fibrocell.com/investors/events under the event, “Fibrocell FCX-007 Conference Call & Webcast,” and will be archived there for 30 days.

READ:  Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients

Source: Fibrocell Science Inc, 405 Eagleview Blvd, Exton PA 19341

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee